Trial Profile
Study of Colestyramine (A3384 ) for the treatment of bile acid malabsorption disease (BAM).
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 01 Aug 2016
Price :
$35
*
At a glance
- Drugs Colestyramine (Primary)
- Indications Primary bile acid malabsorption
- Focus Therapeutic Use
- 01 Aug 2016 New trial record